Income Statement (TTM)
China Shineway Pharmaceutical Group Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,592 | 2,656 | 2,838 | 3,020 | 3,122 | 3,224 | 3,354 | 3,485 | 3,718 | 3,951 | 4,242 | 4,534 | 4,525 | 4,517 | 4,361 | 4,205 | 3,991 | 3,778 | 3,561 | 3,344 |
| Change (%) | 2.47 | 6.85 | 6.41 | 3.38 | 3.27 | 4.05 | 3.89 | 6.69 | 6.27 | 7.38 | 6.88 | -0.19 | -0.19 | -3.45 | -3.58 | -5.07 | -5.34 | -5.74 | -6.09 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 657 | 668 | 715 | 761 | 787 | 813 | 855 | 897 | 954 | 1,012 | 1,064 | 1,117 | 1,120 | 1,122 | 1,082 | 1,042 | 994 | 946 | 919 | 891 |
| Change (%) | 1.73 | 6.99 | 6.53 | 3.42 | 3.31 | 5.12 | 4.87 | 6.46 | 6.07 | 5.15 | 4.90 | 0.26 | 0.26 | -3.57 | -3.71 | -4.60 | -4.82 | -2.93 | -3.02 | |
| % of Revenue | 25.33 | 25.15 | 25.18 | 25.21 | 25.22 | 25.23 | 25.49 | 25.73 | 25.67 | 25.62 | 25.09 | 24.63 | 24.74 | 24.85 | 24.82 | 24.79 | 24.91 | 25.05 | 25.80 | 26.64 |
| Gross Operating Profit | 1,935 | 1,988 | 2,123 | 2,259 | 2,334 | 2,410 | 2,499 | 2,588 | 2,763 | 2,938 | 3,178 | 3,417 | 3,406 | 3,394 | 3,278 | 3,162 | 2,997 | 2,832 | 2,642 | 2,453 |
| Change (%) | 2.72 | 6.81 | 6.37 | 3.36 | 3.25 | 3.69 | 3.56 | 6.77 | 6.34 | 8.15 | 7.54 | -0.34 | -0.34 | -3.41 | -3.54 | -5.23 | -5.52 | -6.68 | -7.16 | |
| % of Revenue | 74.67 | 74.85 | 74.82 | 74.79 | 74.78 | 74.77 | 74.51 | 74.27 | 74.33 | 74.38 | 74.91 | 75.37 | 75.26 | 75.15 | 75.18 | 75.21 | 75.09 | 74.95 | 74.20 | 73.36 |
| SG&A | 1,425 | 1,466 | 1,528 | 1,590 | 1,676 | 1,763 | 1,832 | 1,902 | 2,004 | 2,107 | 2,215 | 2,323 | 2,318 | 2,314 | 2,212 | 2,111 | 2,003 | 1,895 | 1,798 | 1,701 |
| Change (%) | 2.85 | 4.23 | 4.06 | 5.46 | 5.18 | 3.93 | 3.78 | 5.41 | 5.13 | 5.11 | 4.87 | -0.20 | -0.20 | -4.38 | -4.59 | -5.10 | -5.38 | -5.13 | -5.41 | |
| % of Revenue | 54.99 | 55.19 | 53.84 | 52.64 | 53.71 | 54.70 | 54.63 | 54.57 | 53.92 | 53.34 | 52.21 | 51.23 | 51.23 | 51.22 | 50.73 | 50.20 | 50.18 | 50.16 | 50.49 | 50.86 |
| R&D | 88 | 100 | 102 | 105 | 109 | 113 | 115 | 116 | 117 | 117 | 127 | 137 | 124 | 110 | 109 | 107 | 104 | 101 | 103 | 106 |
| Change (%) | 12.81 | 2.43 | 2.37 | 3.90 | 3.75 | 1.62 | 1.59 | 0.47 | 0.47 | 8.31 | 7.67 | -9.68 | -10.72 | -1.56 | -1.59 | -3.03 | -3.13 | 2.80 | 2.73 | |
| % of Revenue | 3.41 | 3.75 | 3.60 | 3.46 | 3.48 | 3.50 | 3.41 | 3.34 | 3.14 | 2.97 | 3.00 | 3.02 | 2.73 | 2.45 | 2.49 | 2.55 | 2.60 | 2.66 | 2.90 | 3.17 |
| OpEx | 2,170 | 2,233 | 2,344 | 2,455 | 2,572 | 2,689 | 2,802 | 2,915 | 3,076 | 3,237 | 3,407 | 3,576 | 3,561 | 3,546 | 3,403 | 3,260 | 3,101 | 2,942 | 2,820 | 2,698 |
| Change (%) | 2.92 | 4.97 | 4.74 | 4.76 | 4.54 | 4.19 | 4.02 | 5.53 | 5.24 | 5.24 | 4.98 | -0.42 | -0.42 | -4.04 | -4.21 | -4.88 | -5.12 | -4.15 | -4.33 | |
| % of Revenue | 83.73 | 84.09 | 82.62 | 81.31 | 82.40 | 83.42 | 83.54 | 83.64 | 82.74 | 81.94 | 80.30 | 78.88 | 78.70 | 78.52 | 78.04 | 77.53 | 77.69 | 77.87 | 79.19 | 80.68 |
| Operating Income | 422 | 422 | 493 | 564 | 549 | 534 | 552 | 570 | 642 | 714 | 836 | 958 | 964 | 970 | 957 | 945 | 890 | 836 | 741 | 646 |
| Change (%) | 0.15 | 16.79 | 14.38 | -2.65 | -2.72 | 3.34 | 3.23 | 12.59 | 11.18 | 17.10 | 14.60 | 0.65 | 0.65 | -1.31 | -1.33 | -5.75 | -6.10 | -11.35 | -12.81 | |
| % of Revenue | 16.27 | 15.91 | 17.38 | 18.69 | 17.60 | 16.58 | 16.46 | 16.36 | 17.26 | 18.06 | 19.70 | 21.12 | 21.30 | 21.48 | 21.96 | 22.47 | 22.31 | 22.13 | 20.81 | 19.32 |
| Interest Expense | -16 | -17 | -11 | -5 | -3 | -1 | -1 | -0 | -0 | -1 | -1 | -0 | -2 | -3 | -4 | -5 | -6 | -6 | -8 | -9 |
| Change (%) | 2.30 | -36.31 | -57.02 | -35.72 | -57.07 | -38.00 | -61.29 | 47.34 | 42.05 | -13.81 | -16.02 | 250.11 | 71.44 | 48.98 | 32.88 | 6.56 | 6.16 | 24.57 | 19.72 | |
| % of Revenue | -0.63 | -0.63 | -0.37 | -0.15 | -0.09 | -0.04 | -0.02 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.04 | -0.06 | -0.09 | -0.13 | -0.14 | -0.16 | -0.21 | -0.27 |
| Net Income | 382 | 295 | 322 | 350 | 453 | 557 | 568 | 579 | 651 | 723 | 803 | 883 | 926 | 970 | 1,037 | 1,105 | 972 | 840 | 834 | 828 |
| Change (%) | -22.79 | 9.28 | 8.49 | 29.58 | 22.83 | 2.04 | 2.00 | 12.38 | 11.02 | 11.09 | 9.98 | 4.89 | 4.66 | 6.96 | 6.51 | -11.97 | -13.60 | -0.70 | -0.71 | |
| % of Revenue | 14.74 | 11.11 | 11.36 | 11.58 | 14.52 | 17.27 | 16.93 | 16.63 | 17.51 | 18.30 | 18.93 | 19.48 | 20.47 | 21.47 | 23.78 | 26.27 | 24.36 | 22.24 | 23.42 | 24.77 |
Source: Capital IQ
